242 related articles for article (PubMed ID: 30389760)
1. Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study.
Galaal K; Lopes A; Pritchard C; Barton A; Wingham J; Marques EMR; Faulds J; Palmer J; Vickery PJ; Ralph C; Ferreira N; Ewings P
BMJ Open; 2018 Nov; 8(11):e024108. PubMed ID: 30389760
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial.
Khan KS; Moore P; Wilson M; Hooper R; Allard S; Wrench I; Roberts T; McLoughlin C; Beresford L; Geoghegan J; Daniels J; Catling S; Clark VA; Ayuk P; Robson S; Gao-Smith F; Hogg M; Jackson L; Lanz D; Dodds J
Health Technol Assess; 2018 Jan; 22(2):1-88. PubMed ID: 29318985
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cost-effectiveness of teen online problem-solving for adolescents who have survived an acquired brain injury in the UK: protocol for a randomised, controlled feasibility study (TOPS-UK).
Limond J; Wade SL; Vickery PJ; Jeffery A; Warren FC; Hawton A; Smithson J; Ford T; Haworth S; Adlam AR
BMJ Open; 2019 Aug; 9(8):e029349. PubMed ID: 31444185
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer.
Kietpeerakool C; Supoken A; Laopaiboon M; Lumbiganon P
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011732. PubMed ID: 26801659
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of cell salvage and donor blood transfusion during caesarean section: results from a randomised controlled trial.
McLoughlin C; Roberts TE; Jackson LJ; Moore P; Wilson M; Hooper R; Allard S; Wrench I; Beresford L; Geoghegan J; Daniels J; Catling S; Clark VA; Ayuk P; Robson S; Gao-Smith F; Hogg M; Lanz D; Dodds J; Khan KS;
BMJ Open; 2019 Feb; 9(2):e022352. PubMed ID: 30782867
[TBL] [Abstract][Full Text] [Related]
6. Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial.
Oakley LL; Awogbade M; Brien S; Briley A; Chorozoglou M; Drasar E; Johns J; Rhodes E; Robinson V; Seed P; Sharif J; Singh C; Telfer P; Thompson H; Watt-Coote I; Howard J; Oteng-Ntim E
Trials; 2020 Apr; 21(1):347. PubMed ID: 32312326
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial comparing intraoperative cell salvage and autotransfusion with standard care in the treatment of hip fractures: a protocol for the WHITE 9 study.
Dickenson E; Griffin XL; Achten J; Mironov K; O'Connor H; Parsons N; Murphy M; Wyse M; Mason J; Appelbe D; Athwal A; Griffin D
BMJ Open; 2022 Jun; 12(6):e062338. PubMed ID: 35676006
[TBL] [Abstract][Full Text] [Related]
8. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of cell salvage in pediatric surgery.
Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
[TBL] [Abstract][Full Text] [Related]
10. Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO).
Khan KS; Moore PAS; Wilson MJ; Hooper R; Allard S; Wrench I; Beresford L; Roberts TE; McLoughlin C; Geoghegan J; Daniels JP; Catling S; Clark VA; Ayuk P; Robson S; Gao-Smith F; Hogg M; Lanz D; Dodds J;
PLoS Med; 2017 Dec; 14(12):e1002471. PubMed ID: 29261655
[TBL] [Abstract][Full Text] [Related]
11. Thromboelastography-guided blood transfusion during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a prospective randomised controlled trial.
Wang S; Zhang Q; Chen L; Liu G; Liu PF
BMJ Open; 2020 Nov; 10(11):e042741. PubMed ID: 33184089
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
14. De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial.
Voorn VM; Marang-van de Mheen PJ; So-Osman C; Kaptein AA; van der Hout A; van den Akker-van Marle ME; Koopman-van Gemert AW; Dahan A; Nelissen RG; Vliet Vlieland TP; van Bodegom-Vos L
Implement Sci; 2014 Apr; 9():48. PubMed ID: 24755214
[TBL] [Abstract][Full Text] [Related]
15. Irrationality of Allogeneic Red Blood Cell Transfusion in Intraoperative Cell Salvage Patients: a Retrospective Analysis.
Ma M; Yu XR; Wang Y; Huang YG; Lu SF; Tian Y; Bai B
Chin Med Sci J; 2018 Jun; 33(2):77-83. PubMed ID: 29976276
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
17. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness.
Gurusamy K; Vale CL; Pizzo E; Bhanot R; Davidson BR; Mould T; Mughal M; Saunders M; Aziz O; O'Dwyer S
BMJ Open; 2020 May; 10(5):e039314. PubMed ID: 32404398
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial.
Liu Y; Li X; Che X; Zhao G; Xu M
BMC Pregnancy Childbirth; 2020 Aug; 20(1):452. PubMed ID: 32767971
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
